Anti-TNF-α therapy as a clinical intervention for periprosthetic osteolysis

Description

Aseptic loosening of total joint arthroplastics due to periprosthetic osteolysis is a frequent cause of implant failure. The absence of clinical interventions to arrest or prevent this complication limits the use of total joint replacement especially in younger patients. Here we review recent studies implicating tumor necrosis factor (TNF)-α in periprosthetic osteolysis and the rationale for clinical studies of anti-TNF therapy and other interventions for periprosthetic loosening.

Resources

Name Format Description Link
21 Visit the original government dataset for complete information, documentation, and data access. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC129996/

Tags

  • tnf-alpha-therapy
  • aseptic-loosening
  • nih
  • joint-arthroplasty
  • periprosthetic-osteolysis

Topics

Categories